Abstract:BACKGROUND:An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel antimicrobial agents.OBJECTIVE:As a part of our ongoing studies toward the development of novel antibacterial agents, the synthesis and antibacterial activity of a series of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives will be discussed in this study.METHOD:(Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives were designed, synthesized and evaluated for antibacterial activity. The structures were confirmed by IR, 1H NMR, 13C NMR and mass spectrometry. All of the synthesized compounds were evaluated in vitro using a 96-well microtiter plate and a serial dilution method to obtain their minimum inhibitory concentration (MIC) values against a variety of different strains, including multidrug-resistant clinical isolates.RESULTS:The antibacterial test in-vitro showed that most compounds in series 7 and 9 exhibited significant inhibitory activities against anaerobic bacteria (Streptococcus mutans) strains with a MIC value of 1 µg/mL. Compounds 7c and 9c showed the most potent activity against MRSA (3167 and 3506) with a minimum inhibitory concentration (MIC) value of 1 µg/mL, which is equivalent to moxifloxacin and greater than gatifloxacin, oxacillin and norfloxacin. Additionally, compound 9c showed potent antibacterial activity against Bacillus subtilis (aerobic bacteria) with a MIC value of 2 µg/mL.CONCLUSION:The work suggests that these type of rhodanine compounds had a better potent activity against MRSA compared with other perviously reported rhodanine derivatives, which might provide a valuable information for the development of new antibacterial agents against multidrug-resistant clinical isolates MRSA.

Synthesis and Biological Evaluation of (E)-1-(substituted)-3-phenylprop-2-en-1-ones Bearing Rhodanines As Potent Anti-Microbial Agents

Synthesis and biological evaluation of N-substituted rhodanine derivatives bearing chalcone moiety as potent antimicrobial agents

Synthesis and Antimicrobial Evaluation of L-Phenylalanine-Derived C5-Substituted Rhodanine and Chalcone Derivatives Containing Thiobarbituric Acid or 2-Thioxo-4-thiazolidinone

Synthesis and Biological Evaluation of Rhodanine Derivatives Bearing a Quinoline Moiety As Potent Antimicrobial Agents

Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity.

Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.

Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents

Synthesis and antibacterial activity of chalcone and rhodanine derivatives

Synthesis and Antibacterial Evaluation of Rhodanine-Based 5-Aryloxy Pyrazoles Against Selected Methicillin Resistant and Quinolone-Resistant Staphylococcus Aureus (MRSA and QRSA).

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Synthesis and Antibacterial Activity of Novel 1,3-Diphenyl-1h-pyrazoles Functionalized with Phenylalanine-Derived Rhodanines

Synthesis and Antimicrobial Evaluation of 5-Aryl-1,2,4-triazole-3-thione Derivatives Containing A Rhodanine Moiety

Synthesis and potential antibacterial activity of new rhodanine-3-acetic acid derivatives

Novel Arylhydrazone Derivatives Bearing a Rhodanine Moiety: Synthesis and Evaluation of Their Antibacterial Activities

Synthesis and anti-bacterial activity of some heterocyclic chalcone derivatives bearing thiofuran, furan, and quinoline moieties.

Synthesis and Anti-bacterial Activity of Novel Chalcone Derivatives Containing 2,4-Thiazolidinedione-3-acetic Acid Moiety

Synthesis and Biological Evaluation of Chalcone Derivatives Containing Aminoguanidine or Acylhydrazone Moieties

Synthesis and evaluation of the antimicrobial activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one derivatives.

Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents.

ChemInform Abstract: the Synthesis and Anti‐Bacterial Activities of N‐Carboxymethyl Rhodanines

Synthseis and Antibacterial Activities of Some 3-(2-Hydroxy-4,6-dimethoxyphenyl)-5-aryl-isoxazolines